Aeragen

Aeragen was a private medical device startup formed out of a New York University COVID-19 task force in 2020 to develop portable patient-containment and air-handling technologies for hospitals, clinics, and EMS settings. Its core product concept, referred to publicly as AerVent, was designed to reduce healthcare-worker exposure to aerosolized pathogens by creating a mobile isolation environment around patients. The company appears to have operated at an early stage, with prototype development, patent activity, and pre-seed/incubator support, but no clear evidence of commercial launch or an advanced multi-product pipeline. Multiple startup databases have listed Aeragen as healthcare/medical device focused, while NYU's startup portfolio has marked it inactive. Overall, Aeragen appears to have been an early-stage medtech venture focused on infection-control hardware rather than a therapeutics developer.